Man Group’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-296,339
Closed -$4.56M 2443
2025
Q4
$4.56M Sell
296,339
-417,890
-59% -$4.6M 0.01% 1130
2025
Q3
$7.09M Buy
714,229
+266,382
+59% +$2.77M 0.01% 936
2025
Q2
$4.44M Buy
447,847
+404,175
+925% +$4.26M 0.01% 1096
2025
Q1
$566K Buy
+43,672
New +$578K ﹤0.01% 1752
2024
Q4
Sell
-31,648
Closed -$353K 2033
2024
Q3
$353K Sell
31,648
-220,139
-87% -$2.43M ﹤0.01% 1738
2024
Q2
$2.83M Sell
251,787
-32,277
-11% -$376K 0.01% 1233
2024
Q1
$3.53M Buy
284,064
+8,818
+3% +$115K 0.01% 1107
2023
Q4
$3.85M Buy
+275,246
New +$3.82M 0.01% 1063
2023
Q3
Hold
0
1172
2021
Q1
Sell
-10,468
Closed -$47K 1887
2020
Q4
$47K Sell
10,468
-4,200
-29% -$19K ﹤0.01% 1794
2020
Q3
$63K Buy
+14,668
New +$105K ﹤0.01% 1755

Other funds holding DVAX

Man Group's DVAX Position: Q1 2026 in Review

Man Group sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 296,339 shares — an estimated $4.56M sold.

Man Group first reported a position in DVAX in Q3 2020 and held it in 10 quarters. The position peaked at $7.09M in Q3 2025. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

  • Man Group reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
  • Man Group sold 296,339 Dynavax Technologies shares in Q1 2026, an estimated $4.56M.
  • Man Group first reported a position in Dynavax Technologies in Q3 2020 and held it in 10 quarters.
  • Man Group's Dynavax Technologies position peaked at $7.09M in Q3 2025.
  • 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.